title: Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
authors.affiliation: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen.
authors.forename: Marieke G G
authors.initials: MG
authors.lastname: Sturkenboom
authors.affiliation: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen.
authors.forename: Mathieu S
authors.initials: MS
authors.lastname: Bolhuis
authors.affiliation: Tuberculosis Centre Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, Department of Pulmonary Diseases and Tuberculosis.
authors.forename: Onno W
authors.initials: OW
authors.lastname: Akkerman
authors.affiliation: Tuberculosis Centre Beatrixoord, University of Groningen, University Medical Center Groningen, Haren, Department of Pulmonary Diseases and Tuberculosis.
authors.forename: Wiel C M
authors.initials: WC
authors.lastname: de Lange
authors.affiliation: Department of Pulmonary Diseases and Tuberculosis, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands email/email, Email: j.w.c.alffenaar@umcg.nl.
authors.forename: Tjip S
authors.initials: TS
authors.lastname: van der Werf
authors.affiliation: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen.
authors.forename: Jan-Willem C
authors.initials: JC
authors.lastname: Alffenaar
mesh_terms: D000995:Antitubercular Agents; D016903:Drug Monitoring; D006801:Humans; D014376:Tuberculosis
chemical_list: D000995:Antitubercular Agents